SG Americas Securities’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-48,300
| Closed | -$17K | – | 3188 |
|
|
2025
Q1 | $17K | Hold |
48,300
| – | – | ﹤0.01% | 3389 |
|
|
2024
Q4 | $54K | Buy |
48,300
+27,700
| +134% | +$2.49M | ﹤0.01% | 2895 |
|
|
2024
Q3 | $13K | Hold |
20,600
| – | – | ﹤0.01% | 3366 |
|
|
2024
Q2 | $48K | Buy |
+20,600
| New | +$1.37M | ﹤0.01% | 2678 |
|
|
2023
Q1 | – | Sell |
-51,800
| Closed | -$4K | – | 3366 |
|
|
2022
Q4 | $4K | Hold |
51,800
| – | – | ﹤0.01% | 2994 |
|
|
2022
Q3 | $149K | Sell |
51,800
-6,200
| -11% | -$391K | ﹤0.01% | 2555 |
|
|
2022
Q2 | $175K | Buy |
58,000
+13,500
| +30% | +$836K | ﹤0.01% | 2767 |
|
|
2022
Q1 | $199K | Sell |
44,500
-350,800
| -89% | -$22.4M | ﹤0.01% | 2438 |
|
|
2021
Q4 | $236K | Sell |
395,300
-209,700
| -35% | -$14.4M | ﹤0.01% | 2587 |
|
|
2021
Q3 | $4.87M | Sell |
605,000
-395,000
| -40% | -$27.8M | 0.02% | 553 |
|
|
2021
Q2 | $3.1M | Sell |
1,000,000
-1,000,000
| -50% | -$66.8M | 0.01% | 851 |
|
|
2021
Q1 | $11.2M | Buy |
2,000,000
+1,319,600
| +194% | +$85.1M | 0.06% | 268 |
|
|
2020
Q4 | $2.31M | Sell |
680,400
-577,100
| -46% | -$34.8M | 0.01% | 1006 |
|
|
2020
Q3 | $5.24M | Sell |
1,257,500
-97,500
| -7% | -$6.76M | 0.03% | 331 |
|
|
2020
Q2 | $3.94M | Buy |
1,355,000
+1,014,000
| +297% | +$77.7M | 0.03% | 462 |
|
|
2020
Q1 | $2.25M | Sell |
341,000
-191,400
| -36% | -$13.2M | 0.02% | 737 |
|
|
2019
Q4 | $1.74M | Buy |
532,400
+257,400
| +94% | +$16.8M | 0.02% | 910 |
|
|
2019
Q3 | $1.97M | Buy |
275,000
+27,000
| +11% | +$1.76M | 0.02% | 968 |
|
|
2019
Q2 | $1.35M | Sell |
248,000
-225,000
| -48% | -$14.8M | 0.01% | 1251 |
|
|
2019
Q1 | $2.53M | Sell |
473,000
-1,329,200
| -74% | -$88.3M | 0.02% | 727 |
|
|
2018
Q4 | $11.2M | Buy |
1,802,200
+183,600
| +11% | +$12.8M | 0.1% | 178 |
|
|
2018
Q3 | $3.65M | Buy |
1,618,600
+203,400
| +14% | +$15.4M | 0.03% | 702 |
|
|
2018
Q2 | $6.35M | Sell |
1,415,200
-151,700
| -10% | -$10.7M | 0.06% | 345 |
|
|
2018
Q1 | $6.55M | Sell |
1,566,900
-443,900
| -22% | -$35.3M | 0.05% | 311 |
|
|
2017
Q4 | $5.11M | Buy |
2,010,800
+434,600
| +28% | +$33M | 0.05% | 367 |
|
|
2017
Q3 | $1.8M | Buy |
1,576,200
+658,000
| +72% | +$50.3M | 0.02% | 863 |
|
|
2017
Q2 | $2.64M | Buy |
918,200
+55,500
| +6% | +$3.69M | 0.02% | 713 |
|
|
2017
Q1 | $3.91M | Sell |
862,700
-1,436,400
| -62% | -$101M | 0.03% | 505 |
|
|
2016
Q4 | $32.9M | Buy |
2,299,100
+457,700
| +25% | +$34M | 0.28% | 71 |
|
|
2016
Q3 | $7.69M | Buy |
1,841,400
+302,100
| +20% | +$24.5M | 0.08% | 236 |
|
|
2016
Q2 | $7.69M | Sell |
1,539,300
-1,494,300
| -49% | -$133M | 0.05% | 274 |
|
|
2016
Q1 | $5.77M | Sell |
3,033,600
-793,800
| -21% | -$71.6M | 0.04% | 349 |
|
|
2015
Q4 | $6.19M | Buy |
+3,827,400
| New | +$398M | 0.04% | 329 |
|
|
2015
Q3 | – | Sell |
-1,869,400
| Closed | -$5.59M | – | 2327 |
|
|
2015
Q2 | $5.59M | Buy |
1,869,400
+1,615,500
| +636% | +$177M | 0.04% | 339 |
|
|
2015
Q1 | $546K | Sell |
253,900
-3,565,800
| -93% | -$362M | ﹤0.01% | 1416 |
|
|
2014
Q4 | $31.4M | Buy |
3,819,700
+1,054,600
| +38% | +$109M | 0.15% | 120 |
|
|
2014
Q3 | $6.04M | Buy |
2,765,100
+1,000,000
| +57% | +$97.9M | 0.04% | 444 |
|
|
2014
Q2 | $1.24M | Sell |
1,765,100
-180,800
| -9% | -$14.1M | 0.01% | 1238 |
|
|
2014
Q1 | $4.91M | Buy |
1,945,900
+215,700
| +12% | +$16.9M | 0.02% | 641 |
|
|
2013
Q4 | $2.18M | Sell |
1,730,200
-46,600
| -3% | -$3.24M | 0.01% | 910 |
|
|
2013
Q3 | $2.73M | Sell |
1,776,800
-60,200
| -3% | -$3.6M | 0.01% | 818 |
|
|
2013
Q2 | $5.93M | Buy |
+1,837,000
| New | +$95.8M | 0.03% | 524 |
|
Other funds holding GILD
VCM
VPM
SG Americas Securities's GILD Position: Q1 2026 in Review
SG Americas Securities reduced its Gilead Sciences (GILD) stake by 24% in Q1 2026, selling an estimated $42.1M and leaving 968,035 shares worth $135M. The position accounts for 0.15% of the portfolio, ranked #115.
SG Americas Securities first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $374M in Q4 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- SG Americas Securities held 968,035 shares of Gilead Sciences worth $135M as of Q1 2026.
- SG Americas Securities sold 300,832 Gilead Sciences shares in Q1 2026, an estimated $42.1M.
- Gilead Sciences made up 0.15% of SG Americas Securities's portfolio in Q1 2026, its #115 holding.
- SG Americas Securities first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- SG Americas Securities's Gilead Sciences position peaked at $374M in Q4 2015.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.